MYCN and neoplasm: In using the neuronal marker STMN1 as a tumor marker for NB, the possibility of different regulatory mechanisms of STMN1 expression and appropriate cut-off values between low-risk NB and high-risk NB with 1p36 LOH and MYCN amplification should also be considered for risk classification.